The Food and Drug Administration (FDA) announced in 2004 that antidepressants were linked to an increase in suicidal thoughts and behavior in children and young adults. Now, GlaxoSmithKline is sending doctors their own warning about an increased risk of suicide attempts in adults taking their antidepressant, Paxil.
The Glaxo study is the first conducted by a drug company to find a link between antidepressants and suicide risks in adults.
The study found:
The FDA recommends doctors carefully monitor adults taking antidepressants for signs of increased suicidal thinking or behavior and depression. GlaxoSmithKline has changed Paxil’s label to reflect the findings, but says data shows the benefits of the drug outweigh the risks for people with depression.